Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 266

Parkwalk debuts Cambridge Enterprise Fund VII

Parkwalk's seventh co-investment vehicle with University of Cambridge will nurture early-stage spinouts from the institution.

Feb 19, 2020

Univercells absorbs KKR financing

KKR's Gamma Biosciences platform has committed $54.1m in financing to a new subsidiary of Univercells, whose existing investors include Takeda.

Feb 19, 2020

FTQ confirms Theodorus investment

Fonds de solidarité FTQ has officially invested $5m in the fourth fund of ULB's Theodorus, with Théo Risopoulos named as the first team member of a new Quebec office.

Feb 19, 2020

Daily deal net: February 18, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Feb 18, 2020

Concirrus burrows away $20m

Insurance underwriting software business Concirrus raised capital to fund product enhancements and entry into new verticals and geographies.

Feb 18, 2020

DB Schenker shells out funding for Volocopter

DB Schenker, the logistics arm of Deutsche Bahn, has invested $21.7m in Volocopter, an air taxi developer already backed by corporates Daimler, Geely Holding and Intel.

Feb 18, 2020

OMass compiles $53.9m series A

University of Oxford-founded OMass Therapeutics has extended its series A round to progress a pipeline targeting immunological and genetic disorders.

Feb 18, 2020

OncoDNA hits the spot in series B round

Ackermans & van Haaren fund Sofinim returned for a $20.6m round that will fund the cancer-analysis software provider's expansion and product development.

Feb 18, 2020

Carbon Clean Solutions captures $16m

CCSL will use the proceeds from the Marubeni and Chevron Technology Ventures-backed round to advance its carbon capture project pipeline.

Feb 18, 2020

Karolinska Development celebrates financial results

Karolinska Development banked a $32.4m annual profit after the successful IPO of Aprea Therapeutics, amid improvements to its operational finances.

Feb 17, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here